✦ LIBER ✦

PAR10 THE COST-UTILITY OF ADALIMUMAB (HUMIRA®) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN DENMARK

✍ Scribed by M Aagren; A Davies; F Pang; B Winding

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR12 IMPROVEMENT IN HEALTH UTILITY IN P

✍ AH Anis; D Guh; LE Melilli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (H

✍ N Bansback; A Brennan; N Sengupta 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

PAR9 EFFECTS OF ADALIMUMAB MONOTHERAPY O

✍ T Mittendorf; R Sterz; W Greiner; J Von der Schulenburg; M Cifaldi; B Dietz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

UT3 ESTIMATING HEALTH UTILITY FROM A PHY

✍ R Boggs; N Sengupta; T Ashraf 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PAR3 VARIATION IN RESOURCE UTILIZATION A

✍ L Van de Putte; R Bergemann; H Rosery; F Pang; B Dietz; H Kupper; T Ashraf 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PAR 13 COST-EFFECTIVENESS OFVALDECOXIB C

✍ RH Alten; B von Scheele; L Gaffney; F Maciver; L Niculescu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB